Fundraising September 15, 2024 – October 1, 2024 About fundraising
52

Mixture design of theophylline retard formulation

Year:
1993
Language:
english
File:
PDF, 578 KB
english, 1993
53

The ionisation properties of acyclovir and deoxyacyclovir

Year:
1993
Language:
english
File:
PDF, 236 KB
english, 1993
55

Market uptake of biologic and small-molecule—Targeted oncology drugs in Europe

Year:
2009
Language:
english
File:
PDF, 146 KB
english, 2009
67

PCN143 WILLINGNESS TO PAY FOR A LIFE-YEAR GAINED FROM THE PERSPECTIVE OF THE GENERAL POPULATION

Year:
2009
Language:
english
File:
PDF, 81 KB
english, 2009
68

PCN82 COST-EFFECTIVENESS ANALYSIS OF HPV VACCINATION IN SLOVENIA

Year:
2009
Language:
english
File:
PDF, 82 KB
english, 2009
69

PCN157 COST-EFFECTIVENESS OF UGT1A1 GENOTYPING IN IRINOTECAN CANCER THERAPY

Year:
2009
Language:
english
File:
PDF, 83 KB
english, 2009
78

Announcements

Year:
1996
Language:
english
File:
PDF, 56 KB
english, 1996
81

Lipophilicity of guanine derivatives

Year:
1989
Language:
english
File:
PDF, 418 KB
english, 1989
90

Cost-Effectiveness of a Novel e-Health Depression Service

Year:
2013
Language:
english
File:
PDF, 248 KB
english, 2013
100

Thematic issue on drug delivery for specific populations

Year:
2015
Language:
english
File:
PDF, 168 KB
english, 2015